Biofrontera Inc (BFRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 6,988 | 9,030 | 8,588 | 12,558 | 9,012 |
| Cost of Goods | 2,045 | 2,642 | 3,268 | 5,272 | 4,877 |
| Gross Profit | 4,943 | 6,388 | 5,320 | 7,286 | 4,135 |
| Operating Expenses | 11,266 | 12,109 | 10,135 | 9,270 | 9,972 |
| Operating Income | -6,278 | -5,079 | -4,547 | -1,712 | -4,960 |
| Interest Expense | 111 | 115 | 106 | 40 | -8 |
| Other Income | -254 | -109 | 449 | 354 | -714 |
| Pre-tax Income | -6,643 | -5,303 | -4,204 | -1,398 | -5,666 |
| Income Tax | 6 | 21 | -1 | -2 | 3 |
| Net Income Continuous | -6,649 | -5,324 | -4,203 | -1,396 | -5,669 |
| Net Income | $-6,649 | $-5,324 | $-4,203 | $-1,396 | $-5,669 |
| EPS Basic Total Ops | -0.62 | -0.57 | -0.47 | 0.69 | -0.98 |
| EPS Basic Continuous Ops | -0.62 | -0.57 | -0.47 | 0.69 | -0.98 |
| EPS Diluted Total Ops | -0.62 | -0.57 | -0.47 | 0.69 | -0.98 |
| EPS Diluted Continuous Ops | -0.62 | -0.57 | -0.47 | 0.69 | -0.98 |
| EPS Diluted Before Non-Recurring Items | -0.59 | -0.57 | -0.47 | N/A | -0.86 |
| EBITDA(a) | $-6,071 | $-4,857 | $-4,328 | $-1,491 | $-4,648 |